ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL

A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selecte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NEDDERMEYER, MELISSA P, BASSLER, KENNETH G, DEEPAK, PHADKE S
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NEDDERMEYER, MELISSA P
BASSLER, KENNETH G
DEEPAK, PHADKE S
description A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0563112B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0563112B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0563112B13</originalsourceid><addsrcrecordid>eNrjZHB39fNw9HN2dVFw8vR3DHP09HF08vTxDIlUCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcDsv1CHD39PP3cFQKC_J1Cnf19eBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAgamZsaGhkZOhMRFKALF4LI4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL</title><source>esp@cenet</source><creator>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</creator><creatorcontrib>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</creatorcontrib><description>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</description><edition>5</edition><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950118&amp;DB=EPODOC&amp;CC=EP&amp;NR=0563112B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950118&amp;DB=EPODOC&amp;CC=EP&amp;NR=0563112B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NEDDERMEYER, MELISSA P</creatorcontrib><creatorcontrib>BASSLER, KENNETH G</creatorcontrib><creatorcontrib>DEEPAK, PHADKE S</creatorcontrib><title>ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL</title><description>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB39fNw9HN2dVFw8vR3DHP09HF08vTxDIlUCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcDsv1CHD39PP3cFQKC_J1Cnf19eBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAgamZsaGhkZOhMRFKALF4LI4</recordid><startdate>19950118</startdate><enddate>19950118</enddate><creator>NEDDERMEYER, MELISSA P</creator><creator>BASSLER, KENNETH G</creator><creator>DEEPAK, PHADKE S</creator><scope>EVB</scope></search><sort><creationdate>19950118</creationdate><title>ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL</title><author>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0563112B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>1995</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NEDDERMEYER, MELISSA P</creatorcontrib><creatorcontrib>BASSLER, KENNETH G</creatorcontrib><creatorcontrib>DEEPAK, PHADKE S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NEDDERMEYER, MELISSA P</au><au>BASSLER, KENNETH G</au><au>DEEPAK, PHADKE S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL</title><date>1995-01-18</date><risdate>1995</risdate><abstract>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP0563112B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ENHANCED BIOAVAILABILITY PHARMACEUTICAL COMPOSITION CONTAINING PROBUCOL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NEDDERMEYER,%20MELISSA%20P&rft.date=1995-01-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0563112B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true